Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora ...